Ranitidine Hydrochloride

TargetMol
Product Code: TAR-T0865
Supplier: TargetMol
CodeSizePrice
TAR-T0865-25mg25mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0865-50mg50mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0865-100mg100mg£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0865-1mL1 mL * 10 mM (in DMSO)£123.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0865-200mg200mg£124.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0865-500mg500mg£134.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Ranitidine Hydrochloride is a member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked.
CAS:
66357-59-3
Formula:
C13H23ClN4O3S
Molecular Weight:
350.86
Pathway:
GPCR/G Protein; Neuroscience; Metabolism; Immunology/Inflammation; Microbiology/Virology
Purity:
0.9913
SMILES:
Cl.CNC(NCCSCc1ccc(CN(C)C)o1)=C[N+]([O-])=O
Target:
P45; Antibacterial; Histamine Receptor

References

1. Luyendyk JP, et al. J Pharmacol Exp Ther,2003, 307(1), 9-16. 2. Okajima K, et al. J Pharmacol Exp Ther,2002, 301(3), 1157-1165. 3. Aasmundstad TA, et al. Pharmacol Toxicol, 1998, 82(6), 272-279. 4. Tukov FF, et al. Toxicol Sci,2007, 100(1), 267-280. 5. Privou C, et al. Neuropharmacology,1998, 37(8), 12019-1032.